[250 Pages Report] The serum separation gels market is anticipated to register a CAGR of 5% during the forecast period, up from US$ 7.61 Bn in 2022 to reach a valuation of US$ 12.39 Bn by 2032.
The serum separation gels market is anticipated to show promising growth prospects during the forecast period.
Attributes | Details |
---|---|
Serum Separation Gels Market CAGR (2022-2032) | 5% |
Serum Separation Gels Market Value (2022) | US$ 7.61 Bn |
Serum Separation Gels Market Value (2032) | US$ 12.39 Bn |
Sales of serum separation gels is expected to rise as serum separation gels allow stable and reliable separation of blood clots and serum with minimal impact on clinical test findings. In addition to this, demand for serum separation gels is rising due to an increase in the number of blood banks around the world, rising rates of chronic diseases, and a sharp rise in the frequency of haematological and chronic infectious diseases around the world.
increase in the number of contract research organizations and investments in the biotechnology industry is also projected to contribute to the growth of the serum separation gels market share.
On the other hand, as the serum separation gels market has minimal entry barriers, it could be a lucrative opportunity for startups. Due to this, the sales of serum separation gels is predicted to grow during the forecast period.
Another factor that is projected to drive the demand for serum separation gels is the performance of serum separation gels, which can be used to attract more customers by delivering a better and more efficient serum separation gel.
Some of the key serum separation gels market trends promoting the demand for serum separation gels include clinical experiments that are confounded by the serum separation gels' inertness and chemical makeup, as the serum separation gels may interact with blood components.
This clears the way for clinical research groups to investigate the development of a better and more reliable serum separation gel that can be commercialized. As a result of these developments, the sales of serum separation gels are projected to grow rapidly during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for serum separation gels is predicted to grow due to an increase in the number of blood tests performed. The serum separation gels market is predicted to rise due to an increase in the number of blood banks testing for blood type and condition.
Furthermore, the sales of serum separation gels is predicted to increase as the number of clinical research studies in pathological science increases. The demand for serum separation gels may be boosted by an increase in the number of contract research businesses in the biotechnology area and increased investment in the serology field.
The high cost of serum separation gels may affect the sales of serum separation gels in some locations. The production of serum separation gels necessitates aseptic conditions, and the serum separation gels market share is predicted to grow as the number of manufacturing plants in emerging nations increases. These factors are forecasted to open up new opportunities in the serum separation gels market.
North America is predicted to witness high sales of serum separation gels during the forecast period. The increased demand for serum separation gels methods in North America is likely due to technological advancements in pathological examinations.
Due to the obvious increased expenditure in haematology and cancer research and development, Europe will be the second most dominant area for serum separation gels market growth.
As there are fewer clinical research businesses in Latin America, the sales of serum separation gels will rise at a slower pace. Following Europe, the Asia Pacific area is expected to see increased demand for serum separation gels as a result of the increased number of biotech enterprises in this region.
In addition, the favourable rise in the sales of serum separation gels is due to the increasing rate of blood cell preservation in animals in this region. China and India are predicted to be the most revenue-generating countries in the global separation gels market.
Qiagen N.V., Cardinal Health Inc., Medtronic PLC, Bio-Rad Laboratories, Microfluidics International Corporation, BioVision, Inc., Danaher Corporation, Becton Dickinson & Company, F. Hoffmann-La Roche Ltd., Merck KGaA, and others are some of the key players identified across the value chain in the serum separation gels market.
Key Developments in the Serum Separation Gels Market
Report Attribute | Details |
---|---|
Growth rate | CAGR of 5% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2014 - 2018 |
Forecast period | 2022 - 2032 |
Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
Segments covered | Product type, end user, region |
Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
Key companies profiled | Qiagen N.V., Cardinal Health Inc., Medtronic PLC, Bio-Rad Laboratories, Microfluidics International Corporation, BioVision, Inc., Danaher Corporation, Becton Dickinson & Company, F. Hoffmann-La Roche Ltd., Merck KGaA Gobain; ?i?ecam Group; Vitro |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The serum separation gels market is forecasted to register a CAGR of 5% during the forecast period.
Key players holding substantial serum separation gels market share include Qiagen N.V., Cardinal Health Inc., Medtronic PLC, Bio-Rad Laboratories, Microfluidics International Corporation, BioVision, Inc., Danaher Corporation, Becton Dickinson & Company, F. Hoffmann-La Roche Ltd., Merck KGaA
As per the analysis, the serum separation gels market share is likely to be US$ 12.39 Bn by 2032.
Demand for serum separation gels is likely to rise owing to an increase in the number of blood banks, rising rates of chronic diseases, and the rising frequency of haematological and chronic infectious diseases around the world.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Serum Separation Gels Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Serum Separating Gel
5.3.2. Serum Separating Gel with Clotting Activator
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Formulation
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Formulation, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Formulation, 2022-2032
6.3.1. Powder Gel
6.3.2. Liquid Gel
6.4. Y-o-Y Growth Trend Analysis By Formulation, 2017-2021
6.5. Absolute $ Opportunity Analysis By Formulation, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical and Biopharmaceutical Companies
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Formulation
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Formulation
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Formulation
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Formulation
10.3.4. By End User
10.4. Key Takeaways
11. Europe Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Formulation
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Formulation
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Formulation
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Formulation
12.3.4. By End User
12.4. Key Takeaways
13. South Asia & Pacific Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Product Type
13.2.3. By Formulation
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Formulation
13.3.4. By End User
13.4. Key Takeaways
14. MEA Serum Separation Gels Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Product Type
14.2.3. By Formulation
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Formulation
14.3.4. By End User
14.4. Key Takeaways
15. Key Countries Serum Separation Gels Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Type
15.1.2.2. By Formulation
15.1.2.3. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Type
15.2.2.2. By Formulation
15.2.2.3. By End User
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Type
15.3.2.2. By Formulation
15.3.2.3. By End User
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Type
15.4.2.2. By Formulation
15.4.2.3. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Type
15.5.2.2. By Formulation
15.5.2.3. By End User
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Type
15.6.2.2. By Formulation
15.6.2.3. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Type
15.7.2.2. By Formulation
15.7.2.3. By End User
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Type
15.8.2.2. By Formulation
15.8.2.3. By End User
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Type
15.9.2.2. By Formulation
15.9.2.3. By End User
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Type
15.10.2.2. By Formulation
15.10.2.3. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Type
15.11.2.2. By Formulation
15.11.2.3. By End User
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Type
15.12.2.2. By Formulation
15.12.2.3. By End User
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Type
15.13.2.2. By Formulation
15.13.2.3. By End User
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Type
15.14.2.2. By Formulation
15.14.2.3. By End User
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Type
15.15.2.2. By Formulation
15.15.2.3. By End User
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Type
15.16.2.2. By Formulation
15.16.2.3. By End User
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Type
15.17.2.2. By Formulation
15.17.2.3. By End User
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Type
15.18.2.2. By Formulation
15.18.2.3. By End User
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Type
15.19.2.2. By Formulation
15.19.2.3. By End User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product Type
15.20.2.2. By Formulation
15.20.2.3. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By Formulation
16.3.4. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Sekisui Diagnostics
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Improve Medical Technology(Nanxiong) Co.,Ltd
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. SGS Polymer Solutions Incorporated
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Shanghai Poyton Mold & Injection Machinery System Co., Ltd
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Thermo Diagnostics Agency,
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. SARSTEDT Trading Co.,Ltd.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Guangzhou Improve Medical Instruments Co. Ltd.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Beijing Hanbaihan Medical Devices Co., Ltd.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. CML Biotech Ltd.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. TUD SDN BHD
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. AB Medical, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports